Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


Simultaneous Spectrophotometric Determination of Valsartan and Ezetimibe in Pharmaceuticals

Sridevi Ramachandran1,2*, Badal Kumar Mandal1 and Sameer G Navalgund2

1School of Advance Sciences, Vellore Institute of Technology University, Vellore Tamil Nadu-632041, 2Analytical Research Department, International Specialty Products (India) Private Limited, 2nd and 3rd Floor Bhupal Towers Somajiguda, Hyderabad Andhra Pradesh - 500082, India.

For correspondence: E-mail: sri_devir@yahoo.com  Tel: +91-040-44747000

Received:  9 March 2011                                              Revised accepted: 23 October, 2011

Tropical Journal of Pharmaceutical Research, December 2011; 10(6): 809-815

http://dx.doi.org/10.4314/tjpr.v10i6.15  

Abstract

 

Purpose: To develop a direct, simple and extraction-free spectrophotometric method for the simultaneous estimation of valsartan and ezetimibe in pharmaceuticals.

Methods: A spectrophotometric method for the determination of valsartan and ezetimibe was developed using acidic dyes, namely, bromophenol blue (BPB) and bromocresol green (BCG). The method was based on selective ion-pair formation between valsartan and the acidic dye. The yellow coloured ion-pair induces a bathochromic shift in the spectrum with maximum absorbance at 425 and 428 nm for BPB and BCG, respectively. The developed method was validated as per ICH guidelines.

Results: With BPB, the ion-pair formed obeyed Beer`s law in the ranges 5 - 40 and 1 - 50 µg/mL for valsartan and ezetimibe, respectively. The assay data for valsartan and ezetimibe were, 99.39 ± 0.53 and 98.17 ± 0.91 %, respectively, for the commercial formulation, and 99.41 ± 0.48 and 98.16± 0.89 %, respectively, for the developed formulation. The method was validated and the correlation coefficient for valsartan and ezetimibe were 0.995 and 0.999, respectively. Recovery was in the range 99.3 - 100.3 %.

Conclusion: The proposed method is reproducible, accurate, robust and suitable for the simultaneous quantitative analysis of the studied drugs in bulk and dosage formulation.

 

Keywords: Valsartan, Ezetimibe, Bromophenol blue, Bromocresol green, Spectrophotometric method.

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net